Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bardoxolone Methyl in COVID-19
NCT04494646Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 2020
- Primary completion
- Jan 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bardoxolone methyl in coronavirus disease 2019 (COVID-19), sponsored by NYU Langone Health. Started Sep 2020; status: completed.
02
Drugs
bardoxolone methyl
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04494646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494646.